Urate-lowering therapy for CKD patients with asymptomatic hyperuricemia without proteinuria elucidated by attribute-based research in the FEATHER Study

Attribute-based medicine is essential for patient-centered medicine. To date, the groups of patients with chronic kidney disease (CKD) requiring urate-lowering therapy are clinically unknown. Herein, we evaluated the efficacy of febuxostat using a cross-classification, attribute-based research appro...

Descripción completa

Detalles Bibliográficos
Autores principales: Kataoka, Hiroshi, Mochizuki, Toshio, Ohara, Mamiko, Tsuruta, Yuki, Iwasa, Naomi, Yoshida, Rie, Tsuchiya, Ken, Nitta, Kosaku, Kimura, Kenjiro, Hosoya, Tatsuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8904814/
https://www.ncbi.nlm.nih.gov/pubmed/35260678
http://dx.doi.org/10.1038/s41598-022-07737-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8904814/
https://www.ncbi.nlm.nih.gov/pubmed/35260678
http://dx.doi.org/10.1038/s41598-022-07737-9

Ejemplares similares